Literature DB >> 15518095

Prevention of nausea and vomiting after middle ear surgery: combination of ondansetron and dexamethasone is the right choice.

Nidhi Bidyut Panda1, Neerja Bharadwaj, Puneet Kapoor, Pramila Chari, Naresh K Panda.   

Abstract

OBJECTIVE: To determine the efficacy of a combination of ondansetron and dexamethasone in preventing postoperative nausea and vomiting after middle ear surgery compared with ondansetron alone.
DESIGN: A prospective, randomized, double-blind study with prestudy power analysis performed to determine the sample size.
SETTING: A tertiary teaching hospital.
METHOD: One hundred patients undergoing tympanomastoidectomy under general anesthesia were included in the study. Patients in group O (n = 50) received ondansetron 4 mg and those in group OD (n = 50) received ondansetron 4 mg with dexamethasone 8 mg 30 minutes before the end of surgery. All patients were monitored for nausea score, episodes of vomiting, and rescue antiemetic requirement in 48 hours after surgery. The total number of complete responders was calculated. Patients' satisfaction at the end of the study period was also estimated.
RESULTS: In patients receiving combination antiemetic (group OD), the nausea score was significantly less (p < .01) at 6, 12, and 24 hours after surgery. The total incidence of vomiting was reduced from 28% in group O to 6% in group OD. Rescue antiemetic requirement was significantly less (p < .01) in group OD. The number of complete responders significantly improved in the combination group (92% vs 62%). The patients were also found to be more satisfied in this group.
CONCLUSION: Prophylaxis with a combination of ondansetron and dexamethasone decreased the incidence of nausea and vomiting after middle ear surgery to a minimum and improved patients' satisfaction significantly in the postoperative period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518095     DOI: 10.2310/7070.2004.02091

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  8 in total

Review 1.  Prophylactic antiemetic effects of dexamethasone versus 5-HT3 receptor antagonists in ear surgery: a systematic review and meta-analysis.

Authors:  Hsin-Ming Liu; Jin-Hua Chen; Chiehfeng Chen; Cher-Ming Liou
Journal:  Int J Clin Pharm       Date:  2021-01-13

Review 2.  Anaesthesia for major middle ear surgery.

Authors:  C Pairaudeau; C Mendonca
Journal:  BJA Educ       Date:  2019-03-06

3.  Comparison of ondansetron and combination of ondansetron and dexamethasone as a prophylaxis for postoperative nausea and vomiting in adults undergoing elective laparoscopic surgery.

Authors:  Basant Bhattarai; Santosh Shrestha; Jeevan Singh
Journal:  J Emerg Trauma Shock       Date:  2011-04

4.  Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

Authors:  Stephanie Weibel; Gerta Rücker; Leopold Hj Eberhart; Nathan L Pace; Hannah M Hartl; Olivia L Jordan; Debora Mayer; Manuel Riemer; Maximilian S Schaefer; Diana Raj; Insa Backhaus; Antonia Helf; Tobias Schlesinger; Peter Kienbaum; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2020-10-19

5.  Comparison of the antiemetic effect of ramosetron with the combination of dexamethasone and ondansetron in middle ear surgery: A double-blind, randomized clinical study.

Authors:  Sameer Desai; M C B Santosh; Rashmi Annigeri; V B Santoshi; Raghavendra Rao
Journal:  Saudi J Anaesth       Date:  2013-07

6.  Comparison of Palonosetron Versus Palonosetron and Dexamethasone for Prevention of Postoperative Nausea and Vomiting After Middle Ear Surgeries: A Randomized Controlled Study.

Authors:  Kanhaiya Kumar; Rajnish Kumar; Mumtaz Hussain; Bibha Kumari; Arvind Kumar
Journal:  Anesth Essays Res       Date:  2022-06-14

7.  Effect of ondansetron in preventing postoperative nausea and vomiting under different conditions of general anesthesia: a preliminary, randomized, controlled study.

Authors:  Dengxin Zhang; Zhiyun Shen; Jie You; Xiaolian Zhu; Qi-Feng Tang
Journal:  Ups J Med Sci       Date:  2013-02-26       Impact factor: 2.384

8.  An overview of the clinical use of ondansetron in preschool age children.

Authors:  Ira Todd Cohen
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.